3-128910053-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 2P and 11B. PM2BP4_ModerateBP6_Very_StrongBP7
The NM_014049.5(ACAD9):āc.1596G>Cā(p.Arg532=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000397 in 1,613,940 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.00013 ( 1 hom., cov: 33)
Exomes š: 0.000030 ( 0 hom. )
Consequence
ACAD9
NM_014049.5 synonymous
NM_014049.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0530
Genes affected
ACAD9 (HGNC:21497): (acyl-CoA dehydrogenase family member 9) This gene encodes a member of the acyl-CoA dehydrogenase family. Members of this family of proteins localize to the mitochondria and catalyze the rate-limiting step in the beta-oxidation of fatty acyl-CoA. The encoded protein is specifically active toward palmitoyl-CoA and long-chain unsaturated substrates. Mutations in this gene cause acyl-CoA dehydrogenase family member type 9 deficiency. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant 3-128910053-G-C is Benign according to our data. Variant chr3-128910053-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 791689.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-128910053-G-C is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-0.053 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ACAD9 | NM_014049.5 | c.1596G>C | p.Arg532= | synonymous_variant | 16/18 | ENST00000308982.12 | |
CFAP92 | NM_001394090.1 | c.*246C>G | 3_prime_UTR_variant | 16/16 | ENST00000645291.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ACAD9 | ENST00000308982.12 | c.1596G>C | p.Arg532= | synonymous_variant | 16/18 | 1 | NM_014049.5 | P1 | |
CFAP92 | ENST00000645291.3 | c.*246C>G | 3_prime_UTR_variant | 16/16 | NM_001394090.1 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152228Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
13
AN:
152228
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000280 AC: 7AN: 249874Hom.: 1 AF XY: 0.00 AC XY: 0AN XY: 135046
GnomAD3 exomes
AF:
AC:
7
AN:
249874
Hom.:
AF XY:
AC XY:
0
AN XY:
135046
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000301 AC: 44AN: 1461594Hom.: 0 Cov.: 32 AF XY: 0.0000330 AC XY: 24AN XY: 727080
GnomAD4 exome
AF:
AC:
44
AN:
1461594
Hom.:
Cov.:
32
AF XY:
AC XY:
24
AN XY:
727080
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000131 AC: 20AN: 152346Hom.: 1 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74490
GnomAD4 genome
AF:
AC:
20
AN:
152346
Hom.:
Cov.:
33
AF XY:
AC XY:
4
AN XY:
74490
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
Asia WGS
AF:
AC:
84
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 15, 2021 | - - |
Likely benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 28, 2024 | - - |
Acyl-CoA dehydrogenase 9 deficiency Benign:1
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 28, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at